BioCryst Pharmaceuticals, Inc(NASDAQ:BCRX) 
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers oral and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; Mundesine, an ora...
Website: http://www.biocryst.com
Founded: 1986
Full Time Employees: 140
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 7.12
H 7.18
L 6.77
C 6.83
V 3,506,688
10EMA 6.83
20EMA 6.83
60EMA 6.83
120EMA 6.83
250EMA 6.83